{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:01:38Z","timestamp":1792530098092,"version":"4.5.0"},"reference-count":54,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025894"],"award-info":[{"award-number":["2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2030765"],"award-info":[{"award-number":["2030765"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Issues<\/jats:title>\n                    <jats:p>Higher delta\u20109\u2010tetrahydrocannabinol (THC) concentration medicinal cannabis products are characterised by a higher THC and minimal cannabidiol (CBD) content. This rapid review aims to systematically summarise and evaluate the available evidence regarding the efficacy and safety of higher THC potency medicinal cannabis products relevant to the Australian market in adult populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach<\/jats:title>\n                    <jats:p>\n                      The rapid literature review protocol was prospectively registered with Open Science Framework:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/HNFUT\">https:\/\/doi.org\/10.17605\/OSF.IO\/HNFUT<\/jats:ext-link>\n                      . The comprehensive search (1\u2010January\u20102014\u201330\u2010July\u20102024) included Medline, EMBASE, EMCARE, CINAHL, SCOPUS and the Cochrane Central Register of Controlled Trials databases. Eligible studies (randomised controlled trials and observational studies) were screened by two independent reviewers and then extracted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Findings<\/jats:title>\n                    <jats:p>\n                      We identified 9969 records, resulting in 15 studies (six RCTs and nine observational), with THC concentrations of 16%\u201322% that met inclusion criteria. Studies examining efficacy for pain (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094), ulcerative colitis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) and chronic obstructive pulmonary disease (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) reported mixed outcomes. Reported adverse events included psychiatric, nervous system and gastrointestinal effects. Validated cannabis use disorder (CUD) screening tools were notably absent from the included studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>Few studies have assessed products equivalent to the Australian Category 5 medicinal cannabis product definition, with most having THC concentrations lower than those available for prescription in Australia, including products reported to contain up to 88% THC. High\u2010quality RCTs and longitudinal studies that incorporate validated CUD screening tools are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No evidence was found on safety or efficacy of prescribed Category 5 medicinal cannabis products with THC concentrations above 22% w\/w (220\u2009mg\/g).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dar.70145","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:07:07Z","timestamp":1775027227000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Higher\n                    <scp>THC<\/scp>\n                    Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review"],"prefix":"10.1111","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-7497","authenticated-orcid":false,"given":"Myfanwy","family":"Graham","sequence":"first","affiliation":[{"name":"Monash Addiction Research Centre Eastern Health Clinical School, Monash University  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Assefa","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre Eastern Health Clinical School, Monash University  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngo","family":"Cong\u2010Lem","sequence":"additional","affiliation":[{"name":"Monash Sustainable Development Institute Evidence Review Service Monash University  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre Eastern Health Clinical School, Monash University  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Australian Medical Association \u201cRobust Regulation Needed to Tackle Medicinal Cannabis Prescribing \u201dhttps:\/\/www.ama.com.au\/media\/robust\u2010regulation\u2010needed\u2010tackle\u2010medicinal\u2010cannabis\u2010prescribing."},{"key":"e_1_2_11_3_1","unstructured":"Australian Health Professional Regulation Agency \u201cRegulators Come Together as One Million Australians Turn to Medicinal Cannabis Treatments \u201d2024 https:\/\/www.ahpra.gov.au\/News\/2024\u201002\u201020\u2010medical\u2010cannabis\u2010treatment.aspx."},{"key":"e_1_2_11_4_1","unstructured":"E.WorthingtonandJ.Miles \u201cMedicinal Cannabis Doctors Investigated by Authorities After Suicide and Hospitalization of Patients \u201d2024 https:\/\/www.abc.net.au\/news\/2024\u201010\u201011\/medicinal\u2010cannabis\u2010company\u2010investigated\u2010by\u2010authorities\/104449400."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1155\/crps\/8870476"},{"key":"e_1_2_11_6_1","unstructured":"Australian Medical Association \u201cAMA Submission to the TGA's Targeted Consultation for the Institution of Legal Provisions to Share Special Access Scheme Information \u201d2025 https:\/\/www.ama.com.au\/sites\/default\/files\/2025\u201005\/AMA_submission_TGA_SAS_reforms_0.pdf?fbclid=IwY2xjawMUmPxleHRuA2FlbQIxMABicmlkETFNNDBSQXRaMmpUUHVGbG9RAR6H65FJ0m_YBg01v4CvCwwmgYaYXiiJDsIGq3KtLBjdUsn\u2010WBQ9wkXvFUWu2w_aem_ndnRxSXJa\u2010iBRQXSG1ihmA."},{"key":"e_1_2_11_7_1","unstructured":"K.SatoandK.O'Toole \u201cTelehealth Medicinal Cannabis Providers are Under\u2010Regulated Medical Bodies AMA and RACGP \u201d2024 https:\/\/www.abc.net.au\/news\/2024\u201004\u201003\/telehealth\u2010medicinal\u2010cannabis\u2010providers\u2010ama\u2010racgp\u2010warnings\/103658706."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674241307158"},{"key":"e_1_2_11_9_1","unstructured":"AMA Queensland \u201cCorrespondence: Concerns About Medicinal Cannabis \u201d2025 https:\/\/amaq.com.au\/Web\/Web\/Advocacy\/Correspondence\/2025Correspondence\/Concerns\u2010about\u2010medicinal\u2010cannabis.aspx."},{"key":"e_1_2_11_10_1","unstructured":"Therapeutic Goods Administration \u201cConsultation: Reviewing the Safety and Regulatory Oversight of Unapproved Medicinal Cannabis Products \u201d2025 https:\/\/consultations.tga.gov.au\/medicines\u2010regulation\u2010division\/test\u2010soms\/."},{"key":"e_1_2_11_11_1","unstructured":"Therapeutic Goods Administration \u201cSAS B Application Dashboard \u201d2025 https:\/\/www.tga.gov.au\/products\/unapproved\u2010therapeutic\u2010goods\/medicinal\u2010cannabis\u2010hub\/medicinal\u2010cannabis\u2010access\u2010pathways\u2010and\u2010usage\u2010data\/medicinal\u2010cannabis\u2010special\u2010access\u2010scheme\u2010data."},{"key":"e_1_2_11_12_1","unstructured":"Therapeutic Goods Administration \u201cMedicinal Cannabis Products by Active Ingredients \u201d2025 https:\/\/www.tga.gov.au\/products\/unapproved\u2010therapeutic\u2010goods\/medicinal\u2010cannabis\u2010hub\/medicinal\u2010cannabis\u2010products\u2010active\u2010ingredients."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16182"},{"key":"e_1_2_11_14_1","unstructured":"Therapeutic Goods Administration \u201cMedicinal Cannabis Vaping Devices that are Approved in Australia \u201d2025 https:\/\/www.tga.gov.au\/products\/unapproved\u2010therapeutic\u2010goods\/medicinal\u2010cannabis\u2010hub\/medicinal\u2010cannabis\u2010vaping\u2010devices\u2010are\u2010approved\u2010australia."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240269"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2023.107740"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2024-112899"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1411631"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.09.041"},{"key":"e_1_2_11_20_1","doi-asserted-by":"crossref","unstructured":"E.Gualdi\u2010RussoandL.Zaccagni \u201cThe Newcastle\u2010Ottawa Scale for Assessing the Quality of Studies in Systematic Reviews \u201d Publications14 no.1(2026):4.","DOI":"10.3390\/publications14010004"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_2_11_22_1","unstructured":"Bedrocan \u201cCannabis Products \u201dhttps:\/\/bedrocan.com\/cannabis\u2010products\/."},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201803-198OC"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246871"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1605"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001464"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13754"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006293"},{"key":"e_1_2_11_29_1","unstructured":"Clinicaltrials.gov \u201cNCT02560545 Cannabinoids Effects on the Pain Modulation System \u201dhttps:\/\/clinicaltrials.gov\/study\/NCT02560545."},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14140"},{"issue":"10","key":"e_1_2_11_31_1","article-title":"\u201cFlower Power\u201d: Controlled Inhalation of THC\u2010Predominant Cannabis Flos Improves Health\u2010Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients","volume":"10","author":"Moreno\u2010Sanz G.","year":"2022","journal-title":"Biomedicine"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S147895151900021X"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419881498"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/20503245231164718"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2014.941130"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001011"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/87551225231180796"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000129"},{"issue":"11","key":"e_1_2_11_39_1","article-title":"The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials","volume":"14","author":"Coelho C. F.","year":"2024","journal-title":"Life (Basel)"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12508"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.630602"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.70118"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.03.007"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS\u201024\u201003819"},{"key":"e_1_2_11_45_1","unstructured":"Royal Australian & New Zealand College of Psychiatrists \u201cClinical Memorandum on the Therapeutic Use of Medicinal Cannabis Products \u201d2024 https:\/\/www.ranzcp.org\/getmedia\/233218fd\u2010068d\u20104846\u2010875e\u20103bf319bb5d0a\/cm\u2010therapeutic\u2010use\u2010of\u2010medicinal\u2010cannabis\u2010products.pdf."},{"key":"e_1_2_11_46_1","unstructured":"Therapeutic Goods Administration \u201cFOI 26\u20131890 \u201d2025 https:\/\/www.tga.gov.au\/sites\/default\/files\/2025\u201008\/FOI%2026\u20101890.PDF."},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/10398562231222818"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002817"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111263"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112680"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2023.307414"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae162"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.793703"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/can.2023.0264"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01543"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70145","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.70145","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T08:46:36Z","timestamp":1779439596000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.70145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/dar.70145"],"URL":"https:\/\/doi.org\/10.1111\/dar.70145","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"2025-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70145"}}